Adheris Health Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Operating Revenue	62.99	98.4	97.96	67.75	38.77
Revenue	62.99	98.4	97.96	67.75	38.77
Revenue Growth (YoY)	-35.98%	0.45%	44.59%	74.74%	303.77%
Cost of Revenue	59.02	78.61	81.18	71.15	46.43
Gross Profit	3.97	19.79	16.78	-3.4	-7.66
Selling, General & Admin	10.71	12.14	13.24	2.66	2.53
Other Operating Expenses	3.13	4.57	5.22	5.24	4.93
Operating Expenses	17.03	20.22	23.81	12.79	10.67
Operating Income	-13.06	-0.43	-7.03	-16.19	-18.33
Interest Expense	-2.87	-1.93	-2.13	-1.54	-0.41
Interest & Investment Income	0.08	0.16	0.05	0	0.04
Other Non Operating Income (Expenses)	-	-	-	-	1.47
EBT Excluding Unusual Items	-15.85	-2.21	-9.11	-17.73	-17.23
Merger & Restructuring Charges	-0.92	-	-1.4	-	-
Asset Writedown	-46.54	-	-	-	-
Pretax Income	-63.31	-2.21	-10.52	-17.73	-17.23
Income Tax Expense	0.01	0.13	0.79	-0.24	-2.86
Earnings From Continuing Operations	-63.32	-2.34	-11.31	-17.49	-14.37
Earnings From Discontinued Operations	3.11	3.13	-	-	-
Net Income to Company	-60.21	0.79	-11.31	-17.49	-14.37
Minority Interest in Earnings	-	-	-	0.14	0.42
Net Income	-60.21	0.79	-11.31	-17.35	-13.95
Net Income to Common	-60.21	0.79	-11.31	-17.35	-13.95
Shares Outstanding (Basic)	566	548	545	378	317
Shares Outstanding (Diluted)	566	597	545	378	317
Shares Change (YoY)	-5.29%	9.57%	44.12%	19.47%	36.47%
EPS (Basic)	-0.11	0.00	-0.02	-0.05	-0.04
EPS (Diluted)	-0.11	0.00	-0.02	-0.05	-0.04
Free Cash Flow	-14.37	5.12	-1.63	-0.55	-12.94
Free Cash Flow Per Share	-0.03	0.01	-0.00	-0.00	-0.04
Gross Margin	6.31%	20.11%	17.13%	-5.01%	-19.75%
Operating Margin	-20.73%	-0.44%	-7.18%	-23.89%	-47.27%
Profit Margin	-95.58%	0.80%	-11.54%	-25.60%	-35.98%
Free Cash Flow Margin	-22.80%	5.21%	-1.67%	-0.81%	-33.36%
EBITDA	-11.44	1.31	-4.78	-14.36	-17.18
EBITDA Margin	-18.16%	1.33%	-4.87%	-21.20%	-44.31%
D&A For EBITDA	1.62	1.74	2.26	1.83	1.15
EBIT	-13.06	-0.43	-7.03	-16.19	-18.33
EBIT Margin	-20.73%	-0.44%	-7.18%	-23.89%	-47.27%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.